REIN THERAPEUTICS INC (RNTX) Stock Cash Flow
NASDAQ:RNTX - US00887A2042 - Common Stock
1.365 USD
+0.1 (+8.33%)
1.27 USD
-0.09 (-6.96%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -59.15M | -62.88M | -15.73M | -27.33M | -26.16M | |||
| Depreciation Amortization | 1.00K | 63.00K | 119.00K | 170.00K | 120.00K | |||
| Income Taxes - Deferred | N/A | -1.55M | N/A | N/A | N/A | |||
| Change In Working Capital | 1.32M | 3.97M | -5.38M | 420.00K | 240.00K | |||
| Other non cash items | 38.16M | 38.12M | 1.19M | 1.88M | 2.05M | |||
| OPERATING CASH FLOW | -21.22M | -22.29M | -19.81M | -24.87M | -23.75M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -160.00K | |||
| Other Investing Activity | N/A | 0.00 | 16.20M | 26.46M | -35.76M | |||
| INVESTING CASH FLOW | N/A | 0.00 | 16.20M | 26.46M | -35.92M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 5.00M | 17.82M | N/A | 0.00 | 55.66M | |||
| Other Financing Activity | N/A | 0.00 | 15.79M | N/A | N/A | |||
| FINANCING CASH FLOW | 5.00M | 17.82M | 15.79M | 0.00 | 55.66M | |||
| Exchange Rate Effect | N/A | 0.00 | -63.00K | N/A | N/A | |||
| CHANGE IN CASH | -16.22M | -4.47M | 12.12M | 1.59M | -4.01M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -21.22M | -22.29M | -19.81M | -24.87M | -23.75M | |||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -160.00K | |||
| FREE CASH FLOW | -21.22M | -22.29M | -19.81M | -24.87M | -23.91M | |||
All data in USD